Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients

Cancer Research

Volumn 61, Issue 12, 2001, Pages 4756-4760

  Schmielau, Jan ^a   Finn, Olivera J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HYDROGEN PEROXIDE; T LYMPHOCYTE RECEPTOR;

ARTICLE; CANCER PATIENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENSITY GRADIENT; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LIPID PEROXIDATION; MONONUCLEAR CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY BURST; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADENOCARCINOMA; BREAST NEOPLASMS; COLONIC NEOPLASMS; GRANULOCYTES; HUMANS; HYDROGEN PEROXIDE; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; MEMBRANE PROTEINS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEOPLASMS; OXIDATIVE STRESS; PANCREATIC NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035874990     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Where have all the T cells gone? Mechanisms of immune evasion by tumors
2. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
3. The mechanism of unresponsiveness to circulating tumor antigen MUCI is a block in intracellular sorting and processing by dendritic cells
4. Tumor's other immune targets: Dendritic cells
5. Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients
6. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells-a mechanism of immune evasion?
7. Delayed hypersensitivity in Hodgkin's disease
8. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
9. Ick in T-cells infiltrating human renal cell carcinoma
10. Decreased expression of the signal-transducing δ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma
11. High frequency of cancer patients with abnormal assembly of the T cell receptor-CD3 complex in peripheral blood T lymphocytes
12. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin therapy
13. L-Arginine regulates the expression of the T cell receptor ζ chain (CD3ζ) in Jurkat cells
14. L-Arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Influence on nitric oxide metabolism
15. Nitrogen oxide levels in patients after trauma and during sepsis
16. Alteration in NFκB/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy
17. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors
18. Th1 and Th2 cytokine response patterns in leukocyte cultures of patients with urinary bladder, renal cell and prostate carcinomas
19. + tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro
20. PBLs of early breast carcinoma patients with a high nuclear grade tumor unlike PBLs of cervical carcinoma patients do not show a decreased TCR ζ expression but are functionally impaired
21. Alterations in, T. Cell receptor and signal transduction molecules in melanoma patients
22. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing ζ molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity
23. Isolation functional analysis of neutropbils
24. Suppressed TCRζ chain expression and cytokine production in pancreatic cancer patients
25. Cellular responses to FMLP challenging: A mini-review
26. The isoprostanes: Unique bioactive products of lipid peroxidation
27. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
28. Elevated plasma levels of F2 α-isoprostane in cystic fibrosis
29. Cytokines and the biology of pancreatic cancer
30. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer
31. Serum tumor necrosis factor in patients with gastric cancer
32. Evidence that tumor necrosis factor α (TNF)-induced activation of neutrophil respiratory burst on biologic surfaces is mediated by the p55 TNF receptor
33. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2